A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN
Open Access
- 1 April 1977
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 309 (8015) , 775-778
- https://doi.org/10.1016/s0140-6736(77)92958-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Conversion of angiotensin I to angiotensin IIThe American Journal of Medicine, 1976
- Mechanisms regulating renin releasePhysiological Reviews, 1976
- Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” HypertensionNew England Journal of Medicine, 1975
- Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulationProgress in Cardiovascular Diseases, 1974
- An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive PatientsNew England Journal of Medicine, 1974
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973
- REDUCTION OF PRESSOR EFFECTS OF ANGIOTENSIN I IN MAN BY SYNTHETIC NONAPEPTIDE (B.P.P.9a OR SQ 20,881) WHICH INHIBITS CONVERTING ENZYMEThe Lancet, 1973
- The renin system: Variations in man measured by radioimmunoassay or bioassayKidney International, 1972